Related content

Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?

By Benzi G.   Moretti A.  

European Journal of Pharmacology, Vol. 346, Iss. 1, 1998-04 ,pp. : 1-13

Elsevier

Access to resources Recommend Favorite

Acetylcholinesterase Inhibitors and Sleep Architecture in Patients with Alzheimer's Disease

By Cooke Jana R.   Loredo Jose S.   Liu Lianqi   Marler Matthew   Corey-Bloom Jody   Fiorentino Lavinia   Harrison Tamara   Ancoli-Israel Sonia  

Drugs & Aging, Vol. 23, Iss. 6, 2006-01 ,pp. : 503-511

Adis International

Access to resources Recommend Favorite

Progress in acetylcholinesterase inhibitors for Alzheimer's disease: an update

By Tumiatti Vincenzo   Bolognesi Maria Laura   Minarini Anna   Rosini Michela   Milelli Andrea   Matera Riccardo   Melchiorre Carlo  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 4, 2008-04 ,pp. : 387-401

Informa Healthcare

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease

By Gauthier S.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1511-1520

Informa Healthcare

Access to resources Recommend Favorite

Duration of Therapy with Acetylcholinesterase Inhibitors in Patients with Mild-to-Moderate Alzheimer's Disease as Reported in the Literature

By Melik Razan El   Dubil Amanda   Pound Melanie W.  

The Consultant Pharmacist, Vol. 29, Iss. 6, 2014-06 ,pp. : 400-407

American Society of Consultant Pharmacists

Access to resources Recommend Favorite